ニュース

Novavax's COVID-flu combo vaccine shows strong immune response in trial
Novavax's COVID-19-influenza vaccines show strong immune response in older adults, paving the way for regulatory approval.
Indulgexpress on MSN26 分
Prior Covid vaccination proved beneficial for acute kidney injury patients: Study
Vaccinated patients hospitalised with Covid-19 who developed acute kidney injury had better outcomes than unvaccinated ...
Why a Covid-19 vaccine could soon cost as much as $150—even if you're insured
Now that Covid vaccines are no longer recommended for healthy children and pregnant people, boosters could be a lot more ...
Pharmaceutical Technology1 時間
Moderna’s mRNA RSV vaccine wins expanded FDA approval for younger adults
The label expansion for Moderna’s jab arrives at a juncture in America’s changing vaccine regulatory landscape.
STAT2 日
‘People inside Moderna are afraid’: As anti-vaccine climate intensifies, the company ...
The recent downturn in biotech has battered Massachusetts’ world-renowned sector, and the political climate has only made it ...
FDA OKs new Moderna COVID-19 vaccine for 65+, others with conditions
The Food and Drug Administration has approved Moderna's new COVID-19 vaccine, days after the federal government tightened ...
Health groups urge insurers to cover COVID-19 shots for pregnant women
The American College of Obstetricians and Gynecologists is urging insurers to continue covering vaccinations during pregnancy in an open letter signed by 30 prominent professional health organizations ...
Vaccinated patients with COVID-related kidney injury face lower dialysis and death risks
Vaccinated patients hospitalized with COVID-19 who developed acute kidney injury had better outcomes than unvaccinated patients with the same condition, new research suggests. The study found ...